Kakizawa K, Shimohira I, Sakurada S, Fujimura T, Murayama K, Ueda H
Department of Molecular Pharmacology and Neuroscience, Nagasaki University, School of Pharmaceutical Sciences, Japan.
Peptides. 1998;19(4):755-8. doi: 10.1016/s0196-9781(97)00482-8.
Metabotropic activities of endomorphin 1, a candidate for endogenous mu-opioid receptor ligands, were examined in comparison with the actions of [D-Ala2, N-Me-Phe4, Gly5ol]-enkephalin/DAMGO, a well-known synthetic mu-opioid agonist. Endomorphin 1 stimulated [35S]GTPgammaS binding to synaptic membranes from the mouse amygdala in a naloxone-reversible manner. DAMGO had the same effect in such preparations. In in situ [35S]GTP-gammaS binding experiments using brain sections, both endomorphin 1 and DAMGO similarly stimulated this binding in specific cellular locations throughout the brain regions. These findings strongly support the view that endomorphin 1 selectively acts on a mu-opioid receptor.
与著名的合成μ阿片受体激动剂[D - Ala2,N - Me - Phe4,Gly5ol] - 脑啡肽/DAMGO的作用相比,对内源性μ阿片受体配体候选物内吗啡肽1的促代谢活性进行了研究。内吗啡肽1以纳洛酮可逆的方式刺激[35S]GTPγS与小鼠杏仁核突触膜的结合。DAMGO在这类制剂中具有相同的作用。在使用脑切片的原位[35S]GTP - γS结合实验中,内吗啡肽1和DAMGO在整个脑区的特定细胞位置同样刺激了这种结合。这些发现有力地支持了内吗啡肽1选择性作用于μ阿片受体的观点。